Statim Pharmaceuticals

Lower cost, easier to use alternative to Narcan® for swab-based delivery of opioid overdose rescue medication via the buccal mucosa (inside cheek).

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Moultonborough, NH 03254, USA
  • Currency USD
  • Founded June 2018
  • Employees 0
  • Incorporation Type C-corp
  • Website statimpharma.com

Company Summary

Statim's platform enables the delivery of drugs and vaccines with a proprietary buccal swab applicator by untrained individuals in emergency situations. The first indication, validated in predictive dog models, replaces Narcan (naloxone) for opioid overdose victims, with the potential to go OTC to increase availability and reduce mortality. The technology can also be applied to drugs like EpiPen, Imigram, Zofran, Children's Tylenol and Ativan.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free